151 results
P
COVID-19 patients, SARS-CoV patients
I/C
Meta-analysis of publicly available dataset, COVID-19 vs SARS-CoV
O
Incidence rate, Mortality rate, Recovery rate
P
household contacts
I/C
SARS-CoV-2 transmission, studies from January to February 2020 vs studies from July 2020 to March 2021
O
secondary attack rate (SAR)
P
COVID-19, SARS-CoV-2
I/C
SARS-CoV-2 infection, control group
O
TSH levels
P
individuals who have experienced SARS-CoV-2 infection
I/C
SARS-CoV-2 infection, no SARS-CoV-2 infection
O
diabetes prevalence and incident cases of diabetes
P
students, staff
I/C
SARS-CoV-2 transmission in schools, community transmission
O
extent of SARS-CoV-2 transmission in schools
P
individuals infected with SARS-CoV-2
I/C
infection with SARS-CoV-2 variants Alpha, Beta, Gamma, or Delta, wild-type virus
O
hospitalization, ICU admission, mortality
P
pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
I/C
polymerase chain reaction (PCR) test for SARS-CoV-2, pregnant women without SARS-CoV-2 infection
O
obstetric and perinatal outcomes
P
5340 individuals
I/C
SARS-CoV, MERS-CoV
O
duration of viral shedding, viable virus shedding
P
INDIVIDUALS WITH PAST SARS-COV-2 INFECTION
I/C
PAST SARS-COV-2 INFECTION, NO PREVIOUS INFECTION
O
RE-INFECTION, SYMPTOMATIC DISEASE, SEVERE DISEASE
P
SARS-CoV-2
I/C
bebtelovimab, other COVID-19 therapies
O
similar rates of hospitalization, ICU admission, and death; low incidence of treatment-emergent adverse events